Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Shimamoto

Showing results (221-230 of 221) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 221 results.
Japanese Journal of Clinical Oncology|January 25, 2000
Alternating combination chemotherapy COP (cyclophosphamide, vincristine, prednisone) and MP (melphalan, prednisone) in multiple myeloma: a multicenter phase II study (JCOG8906). Lymphoma Study Group of the Japan Clinical Oncology GroupT Takenaka, S Shirakawa, C Mikuni, et al.
Pageof 23

Showing results (221-230 of 221) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 221 results.
Japanese Journal of Clinical Oncology|January 25, 2000
Alternating combination chemotherapy COP (cyclophosphamide, vincristine, prednisone) and MP (melphalan, prednisone) in multiple myeloma: a multicenter phase II study (JCOG8906). Lymphoma Study Group of the Japan Clinical Oncology GroupT Takenaka, S Shirakawa, C Mikuni, et al.
Pageof 23